1096 J . Org. Chem., Vol. 63, No. 4, 1998
Bringmann et al.
sufficiently pure for carrying out the next step without
further purification.
s), 7.19-7.31 (15H, m). Anal. Calcd for C32H34BNO4
(HBr salt): C, 65.33; H, 6.00; N, 2.38. Found: C, 64.93;
H, 6.02; N, 2.36.
Crystallization of partially purified 14 from CH2Cl2/
hexanes gave 14 as a white solid, mp 228-230 °C: IR
(CH2Cl2) ν 1759 cm-1; 1H NMR (CDCl3, 400 MHz) δ 2.10
(6H, br s), 2.44 (6H, s), 2.49 (6H, s), 3.89 (6H, s), 6.73
(2H, s), 7.11 (2H, br s), 7.22 (2H, s); 13C NMR (CDCl3,
100 MHz) δ 21.3, 21.7, 23.0, 56.8, 110.0, 113.7, 119.3,
121.3, 122.5, 126.7, 130.4, 138.2, 142.2, 143.7, 156.4,
169.9; HRMS calcd for C32H30O10 574.1839, found
574.1820. Anal. Calcd for C32H30O10: C, 66.89; H, 5.26.
Found: C, 66.54; H, 5.20.
5′,5′′-O-Dia cet yl-N,N-d ib en zyl-6,6′′′,8,8′′′-t et r a -O-
ben zylm ich ella m in e (36). Into a dry Schlenk flask
were placed under argon 60.0 mg (0.11 mmol) of iso-
quinolineboronic acid 35, 37.8 mg (0.050 mmol) of ditri-
flate 26, 6.0 mg (0.003 mmol) of tetrakistriphenylphos-
phinepalladium(0), 29.0 mg (0.16 mmol) of barium
hydroxide, 3 mL of dimethoxyethane, and 1.5 mL of
degassed water. The reaction was heated at 80 °C for 8
h and cooled to room temperature, and volatiles were
removed under vacuum. The residue was subjected to
preparative thin-layer chromatography on deactivated37b
silica gel plates using a 2:1 mixture of petroleum ether/
ethyl acetate as eluent to give 51.0 mg (74%) of 35 in the
2,2′-Bis((1-a cetoxy-8-m eth oxy-6-m eth yl-4-tr iflu o-
r om eth a n esu lfon yl)oxy)n a p h th a len e) (26). To a so-
lution of tetraacetate 14 (2.80 g, 4.90 mmol) in 65 mL of
CH2Cl2 and 65 mL of MeOH was added 1,8-diazabicyclo-
[5.4.0]undec-7-ene (3.50 mL, 23.4 mmol) at room tem-
perature. After 15 min, the solvent was evaporated at
reduced pressure and 50 mL of water was added to the
mixture. The mixture was then extracted with CH2Cl2,
and the organic layer was separated and dried over Na2-
SO4. Evaporation of the solvent gave crude diacetate 25
which was used without purification in the next reaction.
The crude 25 was dissolved in 80 mL of CH2Cl2 at 0 °C,
2,6-lutidine (1.0 mL, 8.5 mmol) was added, and then
trifluoromethanesulfonic anhydride (1.26 mL, 7.50 mmol)
was added dropwise over 3 min. The reaction mixture
was stirred at room temperature for 10 min. The solvent
was evaporated under vacuum, and the resulting oil was
purified by flash column chromatography on silica gel
(CH2Cl2) to give 2.55 g (70% from 14) of 26 as a white
solid. An analytical sample of 26 was obtained by
recrystallization from CH2Cl2/hexane as white flakes, mp
1
form of a light brown solid. Evaluation of the H NMR
spectrum is not worthwhile due to substantial peak
broadening (due to hindered rotation) and overlap: IR
(KBr, HBr salt) ν 3500-3200, 2940, 2900, 1700, 1650,
1570 cm-1. Anal. Calcd for C92H88N2O10 (HBr salt): C,
79.97; H, 6.42; N, 2.03. Found: C, 79.34; H, 6.44; N, 2.16.
Mich ella m in es A (1a ) a n d B (1b). The mixture 36
(50 mg) was dissolved in 2 mL of absolute ethanol and
hydrogenated over 5.0 mg of 10% Pd/C for 14 h at room
temperature and 1 atm of hydrogen. Catalyst was
removed by filtration through a short pad of silica gel,
and the filtrate was heated at reflux for 8 h in MeOH
that had been saturated in the cold with gaseous HCl.
After evaporation of the filtrate, the residue was taken
up in MeOH and chromatographed on LH-20 Sephadex,
eluting with MeOH. The fractions containing mixtures
of 1a and 1b were combined and evaporated. The two
atropoisomers were separated on an HPLC equipped with
a 254 mm detector, using a 2.1 × 25 cm Rainin Dynamax
amine phase column. The crude 1a /1b mixture was
dissolved in 7 mL of 87:13 chloroform/methanol, and 0.25-
mL aliquots were injected and eluted with the same
solvent mixture at a flow rate of 12 mL/min to give a
total of 6.6 mg (21%) of michellamine A (1a ) and 16.5
mg (53%) of michellamine B (1b) which were identical
with authentic samples of naturally derived 1a and 1b.
1
190-191 °C: IR (CH2Cl2) ν 1766, 1421, 1205 cm-1; H
NMR (CDCl3, 400 MHz) δ 2.07 (6H, br s), 2.56 (6H, s),
3.93 (6H, s), 6.83 (2H, s), 7.40 (2H, br s), 7.48 (2H, s); 13
C
NMR (CDCl3, 100 MHz) δ 21.0, 23.1, 56.9, 110.9, 113.4,
119.4 (q, J ) 320 Hz) 119.6, 120.7, 121.9, 125.9, 130.3,
140.5, 142.7, 144.7, 156.3; HRMS calcd for C30H24S2O12F6
754.0613, found 754.0608. Anal. Calcd for C30H24S2O12F6:
C, 47.75; H, 3.21. Found: C, 47.66; H, 3.18.
(1R,3R)-N-Ben zyl-6,7-bis(ben zyloxy)-1,3-d im eth yl-
1,2,3,4-tetr a h yd r oisoqu in olin e-5-bor on ic Acid (35).
A solution of 120 mg (0.22 mmol) of bromoisoquinoline
349,10,35 in 10 mL of dry THF under argon was cooled to
-78 °C. Over the course of 10 min, 0.16 mL (0.24 mmol)
of a 1.5 M solution of n-BuLi in hexanes was added and
the reaction mixture was stirred 50 min, resulting in an
orange solution. Freshly distilled (from sodium) tri-
methyl borate (0.12 mL, 1.11 mmol) was added, and the
reaction mixture was allowed to warm to room temper-
ature overnight. Ten milliliters of water was added, and
the mixture was extracted five times with 10-mL portions
of CH2Cl2. The combined organic extracts were dried
over MgSO4 and evaporated under vacuum. The residue
was chromatographed on deactivated (7.5% NH3)37b silica
gel using 4:1 petroleum ether/ethyl acetate to give, after
recrystallization from ethanol/petroleum ether, 100 mg
(89%) of boronic acid 35 as a colorless solid, mp 106-
1a : [R]23 ) -8.3 (c ) 0.4 in MeOH) (lit.2 -10.5, c )
D
0.83 in MeOH); CD ∆ꢀ209 -98.3, ∆ꢀ242 +24.6, ∆ꢀ258 +17.4;
IR (KBr, diacetate) ν 3550-3100, 2960, 2910, 1690, 1600
cm-1; 1H NMR (d4-MeOH, 500.1 MHz) δ 1.21 (6H, d, J )
6.5 Hz), 1.63 (6H, d, J ) 6.5 Hz), 2.12 (2H, m), 2.34 (6H,
s), 2.81 (2H, m) 3.64 (2H, m), 4.10 (6H, s), 4.74 (2H, q, J
) 6.5 Hz), 6.43 (2H, s), 6.75 (2H, s), 6.85 (2H, s), 7.30
(2H, s); 13C NMR (d4-MeOH, 125.0 MHz) δ 18.4, 19.3,
22.1, 33.1, 45.1, 49.4, 57.0, 102.0, 108.0, 113.1, 115.2,
119.1, 120.4, 124.2, 133.1, 134.7, 136.7, 137.5, 152.2,
155.5, 156.9, 159.1.
1b: [R]23 ) -16.2 (c ) 0.72 in MeOH) (lit.2 -14.8, c )
D
0.74 in MeOH); CD ∆ꢀ209 -53.8, ∆ꢀ214 -53.8; IR (KBr,
HBr salt) ν 3600-3150, 2960, 2910, 1600 cm-1; 1H NMR
(d4-MeOH, 500.1 MHz) δ 1.16 (3H, d, J ) 6.0 Hz), 1.19
(3H, d, J ) 6.5 Hz), 1.59 (3H, d, J ) 6.5 Hz), 1.63 (6H, d,
J ) 6.5 Hz), 2.03 (1H, dd, J ) 18.5, 11.5 Hz), 2.25 (1H,
dd, J ) 18.5, 4.5 Hz), 2.33 (3H, s), 2.36 (3H, s), 2.42 (1H,
dd, J ) 18.5, 11.3 Hz), 2.69 (1H, dd, J ) 18.5, 4.0 Hz),
3.48-3.55 (2H, m), 4.09 (3H, s), 4.10 (3H, s), 4.62 (1H, q,
J ) 6.0 Hz), 4.66 (1H, q, J ) 6.0 Hz), 6.41 (2H, s), 6.75
108 °C: [R]23 ) +49.3 (c ) 1.5 in MeOH); IR (KBr) ν
D
3600-3100, 3010, 2920, 2910, 2840 cm-1 1H NMR
;
(CDCl3, 200.1 MHz) δ 1.30 (3H, d, J ) 6.6 Hz), 1.35 (3H,
d, J ) 6.7 Hz), 2.79 (1H, dd, J ) 18.0, 11.3 Hz), 3.13 (1H,
dd, J ) 18.0, 4.6 Hz), 3.33 (1H, d, J ) 14.1 Hz), 3.45-
3.56 (1H, m), 3.85 (1H, d, J ) 14.1 Hz), 4.08 (1H, q, J )
6.7 Hz), 5.02 (2H, s), 5.04 (2H, s), 5.92 (2H, s), 6.42 (1H,
(1H, s), 6.84-6.85 (3H, m), 7.26 (1H, s), 7.30 (1H, s); 13
C
NMR (d4-MeOH, 125.0 MHz, diacetate) δ 13.1, 19.1, 20.1,
20.2, 22.1, 22.2, 30.7, 30.7, 33.9, 34.9, 44.5, 44.6, 56.9,